journal article·2017-03-13Open access

EGFR-Targeted Metal Chelating Polymers (MCPs) Harboring Multiple Pendant PEG2K Chains for MicroPET/CT Imaging of Patient-Derived Pancreatic Cancer Xenografts

Yijie Lu, Amanda J. Boyle, Ping-Jiang Cao, David Hedley, Raymond M. Reilly, Mitchell A. Winnik

Abstract

High Resolution Image Download MS PowerPoint Slide In this study, we developed a new generation of metal chelating polymer (MCP) reagents that carry multiple polyethylene glycol (PEG) pendant groups to provide stealth to MCP-based radioimmunoconjugates (RICs). We describe the MCP synthesis for covalent attachment to panitumumab F(ab′) 2 fragments (pmabF(ab′) 2 ) in which different numbers of pendant methoxy-PEG chains [M = 2000, ∼45 ethylene glycol (EG) repeat units, referred to as PEG 2K ] are incorporated into the polymer backbone. The pendant PEG 2K chains were designed to provide a protein-repellant corona so that metal chelators attached closer to the polymer backbone will be less apparent to the physiological environment. DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) groups to chelate 64 Cu were installed on these conjugates to be employed for PET imaging. The conjugation of MCPs to pmabF(ab′) 2 was based on a UV quantifiable bis-aromatic hydrazone formation under mild conditions (pH 5–6) between an aromatic aldehyde introduced on ε-NH 2 groups of lysines in the F(ab′) 2 fragments and a hydrazinonicotinamide (HyNic) group installed on the initiating end of the MCP. Three MCPs with 17 polyglutamide (PGlu) repeat units, DOTA chelators and with an average of 2, 4, and 8 pendant PEG 2K chains were studied to examine their in vitro and in vivo characteristics, as well as their potential for PET/CT imaging. A pmabF(ab′) 2 -MCP conjugate carrying 2 PEG 2K and one carrying 8 PEG 2K pendant chains in the polymer were selected for microPET/CT imaging and biodistribution studies in tumor-bearing mice. Orthotopic pancreatic patient-derived xenografts tumors were visualized by PET/CT imaging. These RICs showed low levels of liver and spleen uptake along with even lower levels of kidney uptake. These encouraging results confirm the stealth properties of the MCPs with pendant PEG 2K chains.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Radiopharmaceutical Chemistry and Applications · Medical Imaging Techniques and Applications · Boron Compounds in Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, University of Toronto, Toronto, Ontario M5S 3H6, Canada

Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario M5S 3M2, Canada

Toronto General Research Institute, University Health Network, Toronto, Ontario M5G 2C4, Canada

Funding

Canadian Cancer Society Research Institute

References (27)

Show source-provided references
1. 10.1016/S0140-6736(10)62307-010.1016/S0140-6736(10)62307-0 ↗
2. 10.1016/j.jamcollsurg.2004.01.00810.1016/j.jamcollsurg.2004.01.008 ↗
3. 10.1016/j.ijrobp.2003.11.04110.1016/j.ijrobp.2003.11.041 ↗
4. 10.2217/imt.09.6610.2217/imt.09.66 ↗
5. 10.1016/j.ijrobp.2003.09.09810.1016/j.ijrobp.2003.09.098 ↗
6. 10.1016/j.nucmedbio.2014.10.00910.1016/j.nucmedbio.2014.10.009 ↗
7. 10.1016/j.nucmedbio.2010.07.00310.1016/j.nucmedbio.2010.07.003 ↗
8. 10.1073/pnas.93.13.681410.1073/pnas.93.13.6814 ↗
9. Anderson C. J. · J. Nucl. Med. · 1998 · 39 · 1944
10. Torchilin V. P. · Crit. Rev. Ther. Drug Carrier Syst. · 1991 · 7 · 275
11. 10.1021/mp500761810.1021/mp5007618 ↗
12. 10.1007/s11095-012-0853-y10.1007/s11095-012-0853-y ↗
13. 10.1021/bm300843u10.1021/bm300843u ↗
14. 10.1021/bm500174p10.1021/bm500174p ↗
15. 10.1002/jlcr.316510.1002/jlcr.3165 ↗
16. 10.1021/ja304837f10.1021/ja304837f ↗
17. 10.1002/ijc.2800610.1002/ijc.28006 ↗
18. 10.1021/bm201823910.1021/bm2018239 ↗
19. 10.1021/bm201011t10.1021/bm201011t ↗
20. 10.1021/acs.biomac.5b0106610.1021/acs.biomac.5b01066 ↗
21. 10.2165/00003088-199528020-0000410.2165/00003088-199528020-00004 ↗
22. 10.1021/ic101378s10.1021/ic101378s ↗
23. 10.1038/sj.ki.500002710.1038/sj.ki.5000027 ↗
24. 10.1002/jbm.82021110610.1002/jbm.820211106 ↗
25. 10.1007/s13346-012-0119-610.1007/s13346-012-0119-6 ↗
26. 10.1103/PhysRevLett.96.23780110.1103/PhysRevLett.96.237801 ↗
27. 10.1021/bc300037w10.1021/bc300037w ↗